Key result
Japan's 2024 coxsackievirus A6 strains shift predominantly to cluster 3, signaling new viral lineage influx.
Why the study?
HFMD is prevalent worldwide and its pathogenicity and antigenicity may change over time, necessitating surveillance of new viral strains.
Observational (n=767)
Yes
A phylogenetic shift in coxsackievirus A6 clusters was observed in Japan in 2024, likely driven by an influx of a new strain from overseas following the relaxation of COVID-19 pandemic restrictions.
May explain Japan's 2024 HFMD surge; leaves open whether cluster 3 requires expanded genomic surveillance.
Hand, foot, and mouth disease (HFMD) caused by enteroviruses is common in children. Recently, coxsackievirus A6 (CVA6) has been identified as a major causative agent. In this study, we conducted a phylogenetic analysis of a part of the VP1 coding region of 194 CVA6 strains detected directly in 767 nasopharyngeal swab or stool samples of HFMD patients in Japan from 2019 to 2024. The detected CVA6 strains were classified into genotype D. Moreover, the strains detected from before 2019 to 2023 belonged to a cluster (cluster 1 and 2), whereas most of the strains detected in 2024 belonged to another cluster (cluster 3). Genetic identity among all detected CVA6 strains was 89.1-100%, and genetic identity within the cluster for each detected strain was 90.6-100% for the before 2019 (cluster 1) strains, 92.6-100% for the 2019-2023 (cluster 2) strains, and 94.5-100% for the 2024 (cluster 3) strains. Most of the strains detected in 2024 were similar to the strains detected in China in 2023, suggesting that the influx of new strains caused the 2024 outbreak in Japan. HFMD is one of the most prevalent diseases worldwide and its pathogenicity and antigenicity may change over time. Surveillance of the influx of new strains from outside Japan will become increasingly important.
No takes yet. Share an insight, caveat, or question.
Tsukagoshi et al. (2025) conducted an observational in Hand, foot, and mouth disease (n=767). Coxsackievirus A6 strains was evaluated. Coxsackievirus A6 strains detected in Japan in 2024 shifted primarily to cluster 3, diverging from the cluster 1 and 2 strains prevalent from 2019 to 2023, suggesting an influx of new viral strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: